United States Antimony (NYSE:UAMY) CEO Gary Evans Purchases 100,000 Shares

Key Points

• CEO Gary Evans of United States Antimony purchased 100,000 shares at an average cost of $6.13, increasing his total ownership to approximately $14.6 million.
• The company's stock recently traded down by 3.0% to $6.20, with a 12-month trading range between $0.49 and $8.17.
• Brokerages have shown confidence in the company, with ratings ranging from "buy" to "strong buy" and price targets varying from $4.50 to $8.50.

United States Antimony Co. (NYSE:UAMY - Get Free Report) CEO Gary Evans purchased 100,000 shares of the firm's stock in a transaction dated Friday, September 26th. The stock was purchased at an average cost of $6.13 per share, for a total transaction of $613,000.00. Following the acquisition, the chief executive officer owned 2,378,818 shares of the company's stock, valued at approximately $14,582,154.34. This trade represents a 4.39% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

United States Antimony Trading Down 3.0%

NYSE UAMY traded down $0.19 during trading on Tuesday, hitting $6.20. 6,376,411 shares of the company's stock traded hands, compared to its average volume of 4,534,029. The stock has a fifty day moving average of $4.58 and a two-hundred day moving average of $3.37. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.24 and a quick ratio of 5.84. United States Antimony Co. has a 12-month low of $0.49 and a 12-month high of $8.17. The firm has a market cap of $798.11 million, a P/E ratio of -155.00 and a beta of 0.05.

Wall Street Analysts Forecast Growth

Several brokerages have commented on UAMY. D. Boral Capital restated a "buy" rating and issued a $5.00 price objective on shares of United States Antimony in a report on Thursday, August 14th. HC Wainwright raised their price target on shares of United States Antimony from $4.50 to $8.50 and gave the company a "buy" rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating and four have issued a Buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of $4.38.

Hedge Funds Weigh In On United States Antimony

Large investors have recently made changes to their positions in the company. Raymond James Financial Inc. purchased a new position in shares of United States Antimony during the 2nd quarter worth about $33,000. ProShare Advisors LLC purchased a new position in shares of United States Antimony during the 2nd quarter worth about $41,000. Penbrook Management LLC purchased a new position in shares of United States Antimony during the 2nd quarter worth about $44,000. Police & Firemen s Retirement System of New Jersey purchased a new stake in United States Antimony in the 2nd quarter valued at about $47,000. Finally, Cetera Investment Advisers purchased a new stake in United States Antimony in the 4th quarter valued at about $40,000. 9.49% of the stock is owned by hedge funds and other institutional investors.

United States Antimony Company Profile

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.